关于明确抗磷脂综合征（APS）分类标准更新的国际共识声明。
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
作者信息
Miyakis S, Lockshin M D, Atsumi T, Branch D W, Brey R L, Cervera R, Derksen R H W M, DE Groot P G, Koike T, Meroni P L, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos P G, Krilis S A
机构信息
St George Hospital, University of New South Wales, Sydney, Australia.
出版信息
J Thromb Haemost. 2006 Feb;4(2):295-306. doi: 10.1111/j.1538-7836.2006.01753.x.
New clinical, laboratory and experimental insights, since the 1999 publication of the Sapporo preliminary classification criteria for antiphospholipid syndrome (APS), had been addressed at a workshop in Sydney, Australia, before the Eleventh International Congress on antiphospholipid antibodies. In this document, we appraise the existing evidence on clinical and laboratory features of APS addressed during the forum. Based on this, we propose amendments to the Sapporo criteria. We also provide definitions on features of APS that were not included in the updated criteria.
自1999年抗磷脂综合征（APS）的札幌初步分类标准发布以来，新的临床、实验室和实验见解在第十一届抗磷脂抗体国际大会之前于澳大利亚悉尼的一次研讨会上进行了探讨。在本文件中，我们评估了该论坛期间讨论的关于APS临床和实验室特征的现有证据。在此基础上，我们提议对札幌标准进行修订。我们还对更新标准中未包括的APS特征提供了定义。
Zotero 插件